Cheung KS, Ng HY, Hui RWH, Lam LK, et al. Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Hepatology 2024;80:916-927.
PMID: 38536017